EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The potential of bee products in clinical trials focused on the side effects of radiotherapy and chemotherapy used for cancer treatment

Shaden A M Khalifa, Aida A Abd El-Wahed, Aamer Saeed, Maria Daglia, Haged H El-Seedi, Zhengxuan Wang, Hussein Sabit, Hongcheng Zhang, Zhiming Guo, Paolo Coghi, Hesham R El-Seedi

Supportive Care in Cancer · 2026-06 · 34 (6)

DOI: 10.1007/s00520-026-10707-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Supportive Care in Cancer, online erschienen am 06.05.2026. Verfasst von Shaden A M Khalifa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Psychiatry Department, Capio Saint Göran's Hospital, Sankt Göransplan 1, 112 19, Stockholm, Sweden. shaden.khalifa.2014@gmail.com. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit nennt 109 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cancer is a major global issue threatening the whole world, especially developing countries. Treatment of cancer using chemotherapy and radiotherapy has several consequences that negatively affect the quality of life of cancer patients. METHODS: Bee products have numerous pharmacological effects and clinical impacts due to their extraordinary chemical composition. The objective of the current work is to shed light on preclinical studies and clinical trials of bee products, particularly propolis, honey, and royal jelly, with special emphasis on their role in reducing the complications of chemotherapy and radiotherapy by employing a variety of databases. The search used specific keywords, including "bee products", "propolis", "honey", "royal jelly", "cancer", "clinical trials", "radiotherapy", and "chemotherapy". Only peer-reviewed randomized controlled trials (RCTs) and published research papers were included. RESULTS: According to the literature review, bee-generated propolis, honey, and royal jelly have been used in animal models to reduce the adverse effects of radiotherapy and chemotherapy. Depending on the kind of cancer, different dosages and treatment times were used for certain bee products. Bee products are used in various forms, such as crude, in capsules, mouthwashes, tablets, and oils. Propolis, royal jelly, and honey are used at dosages up to 400 mg, 1 g, and 50 g, respectively. Clinical trials have further confirmed their efficacy in cancer treatment, either as standalone therapies or as supplements to conventional treatments. CONCLUSION: It is crucial to investigate the active mechanisms of these products further and to include them in additional clinical trials as potential cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansPropolisRoyal JellyHoneyAnimalsFatty AcidsBeesQuality of LifeRandomized Controlled Trials as TopicRadiotherapy

Stichwörter der Autor:innen

Bee productsCancerChemotherapyFeverGastrointestinal and hematologic complicationsOral mucositisRadiotherapyXerostomia

Substanzen

PropolisRoyal JellyAntineoplastic AgentsFatty Acids

Autor:innen und Institutionen

  • Neurology and Psychiatry Department, Capio Saint Göran's Hospital, Sankt Göransplan 1, 112 19, Stockholm, Sweden. shaden.khalifa.2014@gmail.com.
  • International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, 212013, China. shaden.khalifa.2014@gmail.com.
  • Department of Bee Research, Agricultural Research Centre, Plant Protection Research Institute, Giza, 12627, Egypt.
  • Department of Chemistry, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
  • International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, 212013, China.
  • Faculty of Medicine, Riga Stradins University (RSU), Riga, 1007, Latvia.

Zitieren

APA

Khalifa, S. A. M., El-Wahed, A. A. A., Saeed, A., Daglia, M., El-Seedi, H. H., Wang, Z., Sabit, H., Zhang, H., Guo, Z., Coghi, P., & El-Seedi, H. R. (2026). The potential of bee products in clinical trials focused on the side effects of radiotherapy and chemotherapy used for cancer treatment. Supportive Care in Cancer, 34(6). https://doi.org/10.1007/s00520-026-10707-w

Vancouver

Khalifa SAM, El-Wahed AAA, Saeed A, Daglia M, El-Seedi HH, Wang Z, et al. The potential of bee products in clinical trials focused on the side effects of radiotherapy and chemotherapy used for cancer treatment. Supportive Care in Cancer. 2026;34(6). doi:10.1007/s00520-026-10707-w

BibTeX
@article{Khalifa2026,
  author = {Khalifa, Shaden A M and El-Wahed, Aida A Abd and Saeed, Aamer and Daglia, Maria and El-Seedi, Haged H and Wang, Zhengxuan and Sabit, Hussein and Zhang, Hongcheng and Guo, Zhiming and Coghi, Paolo and El-Seedi, Hesham R},
  title = {The potential of bee products in clinical trials focused on the side effects of radiotherapy and chemotherapy used for cancer treatment},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {6},
  doi = {10.1007/s00520-026-10707-w}
}
Kostenlos starten →